Case Report: Retrospective pharmacist-led multidimensional assessment in a patient with late-onset first-episode mania and elevated creatine kinase
Frontiers in Psychiatry · 19.11.2026 · 17
DOI: 10.3389/fpsyt.2026.2007120 ↗Kurz gefasst
Fallbericht in der Zeitschrift Frontiers in Psychiatry, online erschienen am 19.11.2026. Verfasst von Pan Zhang und 3 weiteren Autor:innen. Die Arbeit nennt 38 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
Background
Late-onset first-episode mania (LOFEM) in adults aged ≥50 years is rare and frequently complicated by cerebrovascular lesions, multimorbidity, and polypharmacy, all of which increase the risk of adverse events such as rhabdomyolysis. Differentiating agitation-related from drug-induced creatine kinase (CK) elevation in this setting is clinically challenging but critical for safe pharmacotherapy. This retrospective, post-discharge pharmacist-led multidimensional assessment explored how etiological differentiation could be achieved. Case presentation A 60-year-old woman with no prior psychiatric history presented with first-episode mania. On day 2, after a single 50 mg dose of quetiapine and an intramuscular injection of diazepam on day 1 (baseline CK was not measured), her CK was 780.9 U/L and myoglobin 112.61 ng/mL, consistent with mild biochemical rhabdomyolysis without acute kidney injury. Quetiapine was continued and titrated to 200 mg/day, combined with valproate and modified electroconvulsive therapy. CK normalized by day 21 and the patient achieved full recovery of psychiatric symptoms.
Conclusions
A post-discharge, retrospective multidimensional pharmaceutical assessment (Naranjo scale, Beers criteria, multi-database drug-drug interaction analysis, and geriatric dose evaluation) indicated that the overall picture was most consistent with mild biochemical rhabdomyolysis related to manic agitation and dehydration/exertion, with intramuscular diazepam as an additional confounder. Quetiapine cannot be excluded as a contributor. NMS was not clinically supported.
Zitieren
APA
Zhang, P., Wei, C., Huang, H., & Diao, J. (2026). Case Report: Retrospective pharmacist-led multidimensional assessment in a patient with late-onset first-episode mania and elevated creatine kinase. Frontiers in Psychiatry, 17. https://doi.org/10.3389/fpsyt.2026.2007120
Vancouver
Zhang P, Wei C, Huang H, Diao J. Case Report: Retrospective pharmacist-led multidimensional assessment in a patient with late-onset first-episode mania and elevated creatine kinase. Frontiers in Psychiatry. 2026;17. doi:10.3389/fpsyt.2026.2007120
BibTeX
@article{Zhang2026,
author = {Zhang, Pan and Wei, Chunxiang and Huang, Haoyang and Diao, Junlin},
title = {Case Report: Retrospective pharmacist-led multidimensional assessment in a patient with late-onset first-episode mania and elevated creatine kinase},
journal = {Frontiers in Psychiatry},
year = {2026},
volume = {17},
doi = {10.3389/fpsyt.2026.2007120}
}
EUVIMED